MedPath

MINT-LOSARTAN/HCTZ

MINT-LOSARTAN/HCTZ

Approved
DIN Number

02389665

Drug Class

Human

Market Date

Jul 27, 2012

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02389665
AIG Number0233168003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA01 LOSARTAN AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:32.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE
LOSARTAN POTASSIUMActive
Strength: 100 MG
Monograph: LOSARTAN POTASSIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.